Skip to main content
. 2017 Mar 30;8(23):37594–37604. doi: 10.18632/oncotarget.16731

Figure 5. The expression of Bcl-6 in CML-CP and CML-BP patients.

Figure 5

(A) qRT-PCR analysis of the relative expression of Bcl-6 mRNA in CML-CP patients and CML-BP patients and controls. (B) Western blot analysis of Bcl-6 protein in CML-CP patients and CML-BP patients and controls. (C) Western blot analysis of Bcl-6 protein in CML-CP patients and controls. (D) Western blot analysis of Bcl-6 protein in CML-BP patients. Values shown are mean ± SD.